ICER: Antibodies For MS – Including TG’s – Need Big Price Cut For Cost-Effectiveness

 
• By Alaric DeArment
  
ICER released its report on cost-effectiveness of drugs for multiple sclerosis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip